Company overview

Ceva Santé Animale has been ranked as one of the top three fastest growing veterinary pharmaceutical companies in the world for the past five years . We now rank as the ninth largest animal health group globally – having only been founded in 1999! Our expertise centres on the two fields of pharmacy and biology, where we have dedicated teams that aim to meet the specific demands of the livestock , poultry, swine and pet sector. We continually strive to find better solutions to existing and emerging diseases which will in turn improve animal health and productivity.

Our care extends beyond animal welfare. These days, a staggering 75% of all emerging human infectious diseases are of animal origin. Ceva is involved in the fight against the spread of infectious disease that can be transmitted from wild or domestic animals and birds to humans – diseases known as zoonoses, which include avian flu, brucellosis and Q-fever.

Ceva is a visible supporter of and contributor to various welfare and social programmes all over the world. Our work ranges from researching, developing, producing and supplying animal health products to the poorest livestock owners in the world, of which our SOS (Stamp Out Sleeping sickness) programme in Uganda is a good example; to supplying the UK’s largest dog welfare charity with Dog Appeasing Pheromone (DAP) collars, to help make the lives of dogs in shelter less stressful.

Ceva successfully combines profitability with long-term growth.

Our global business operations are divided into three major zones : Europe, North America and the International Zone, which includes Africa/Middle East, Asia/Pacific and South America.

We are active in 37 countries, with also 7 sales offices, 9 research and development centres, 12 factories and 2 275 collaborators worldwide. Our operational activities focus on research and development, manufacturing, sales/marketing and administration.